The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 1974, 112: 822-829.
Copyright © 1974 by The American Association of Immunologists, Inc.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mookerjee, B. K.
Right arrow Articles by Poultar, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mookerjee, B. K.
Right arrow Articles by Poultar, L.

Interaction of Anti-Thymocyte Serum with Hematopoietic Stem Cells1

I. Effects in Vitro and in Vivo

B. K. Mookerjee, Luigi Azzolina and Lyndall Poultar

From the Department of Medicine, State University of New York in Buffalo, Buffalo, New York, and the Medical Research Council Group in Transplantation, University Hospital, Edmonton, Alberta, Canada

Abstract

In vitro incubation of spleen cell suspensions in dilutions of anti-thymocyte globulin (ATG) leads to abrogation of the capacity of such cells to mount a graft-vs-host reaction; however, such incubation leads to considerable inactivation in the content of the hematopoietic stem cells. By prior absorption of the ATG preparation with mouse liver or spleen cells, it was found possible to eliminate the toxicity of ATG toward hematopoietic stem cells without any reduction in its immunosuppressive potency. Administration of ATG to intact animals was found to stimulate endogenous colony formation. Intravenous injection of ATG led to early and significant elevation in the serum level of colony-stimulating factor in the injected animals when compared to that after similar injection of normal horse globulin. Short or long term in vivo administration of anti-thymocyte serum did not lead to reduction in the number of spleen-colonizing stem cells in the bone marrow of the treated animals or in the capacity of such cells to reconstitute lethally irradiated syngeneic animals.

Footnotes

1 This work was supported by grants from the Medical Research Council of Canada and the Veterans Administration.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.